TCM
TNDM icon

Timpani Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Timpani Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.46M Buy
85,946
+28,527
+50% +$1.5M 2.61% 3
2018
Q4 		$2.18M Buy
+57,419
New +$2.03M 1.22% 32

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Timpani Capital Management's TNDM Position: Q1 2019 in Review

Timpani Capital Management increased its Tandem Diabetes Care (TNDM) stake by 50% in Q1 2019, buying an estimated $1.5M and bringing the position to 85,946 shares worth $5.46M. The position accounts for 2.61% of the portfolio, ranked #3.

Timpani Capital Management first reported a position in TNDM in Q4 2018 and has held it in 2 quarters since. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Timpani Capital Management held 85,946 shares of Tandem Diabetes Care worth $5.46M as of Q1 2019.
  • Timpani Capital Management bought 28,527 Tandem Diabetes Care shares in Q1 2019, an estimated $1.5M.
  • Tandem Diabetes Care made up 2.61% of Timpani Capital Management's portfolio in Q1 2019, its #3 holding.
  • Timpani Capital Management first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 2 quarters since.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.